September 16, 2002
Sankyo to License CS-866 Antihypertensive Agent to Dae Woong Sankyo announced on September 10 that it made a license-out agreement with Dae Woong Pharma, the second largest drug manufacturer in Seoul, South Korea, for CS-866 (olmesartan medoxomil) on September 9...read more